
3-Fluoroiodobenzene | CAS:1121-86-4
3-Fluoroiodobenzene
- Name:3-Fluoroiodobenzene
- CAS:1121-86-4
- Synonyms:1-Fluoro-3-iodobenzene
- Molecular Formula:C6H4FI
- Molecular Weight:222.00
- EINESC:214-339-9
Description
Properties
Boiling point | 77-78 ºC (19 mmHg) |
---|---|
Flash point | 67 ºC |
Density | 1.89 |
Refractive index | 1.583-1.585 |
Safety
Symbol(GHS) | Xi |
---|---|
Hazard Codes | R36/37/38 |
SDS/MSDS | S26;S37/39 |
SDS
Source | SDS/MSDS Samples |
---|---|
Alfa-Aesar | View & Download |
Sigma-Aldrich | View & Download |
Acros-Organics | View & Download |
Synthetic Route
Name | CAS |
---|
More
Articles
Peer-Reviewed Papers
In silico insight into voltage-gated sodium channel 1.7 inhibition for anti-pain drug discovery.Mingxing Wang et al.Journal of molecular graphics & modelling, 84, 18-28 (2018-05-25)
Synthesis, Biological Evaluation and QSAR Studies of Newer Isoxazole Derivatives.Sahaya Asirvatham et al.Anti-inflammatory & anti-allergy agents in medicinal chemistry, 14(2), 128-137 (2015-08-13)
Time-Resolved Photoelectron Spectroscopy Studies of Isoxazole and Oxazole.Ting Geng et al.The journal of physical chemistry. A, 124(20), 3984-3992 (2020-04-04)
D-Cycloserine destruction by alanine racemase and the limit of irreversible inhibition.Cesira de Chiara et al.Nature chemical biology, 16(6), 686-694 (2020-03-24)
Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules.Sebastian Markmiller et al.Cell, 172(3), 590-604 (2018-01-27)
Switchable Synthesis of Pyrroles and Pyrazines via Rh(II)-Catalyzed Reaction of 1,2,3-Triazoles with Isoxazoles: Experimental and DFT Evidence for the 1,4-Diazahexatriene Intermediate.Nikolai V Rostovskii et al.The Journal of organic chemistry, 82(1), 256-268 (2016-12-16)
BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability.Laura E Jennings et al.Bioorganic & medicinal chemistry, 26(11), 2937-2957 (2018-05-20)
Deprotonation of Isoxazole: A Photoelectron Imaging Study.Adam A Wallace et al.The journal of physical chemistry. A, 124(38), 7768-7775 (2020-08-28)
Microwave accelerated synthesis of isoxazole hydrazide inhibitors of the system xc- transporter: Initial homology model.Afnan A Matti et al.Bioorganic & medicinal chemistry letters, 23(21), 5931-5935 (2013-09-18)
Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly.Sreejith J Nair et al.Nature structural & molecular biology, 26(3), 193-203 (2019-03-06)
Pro-apoptotic activity of novel synthetic isoxazole derivatives exhibiting inhibitory activity against tumor cell growth in vitro.Ilaria Lampronti et al.Oncology letters, 20(5), 151-151 (2020-09-17)
Sea Urchin Embryo Model As a Reliable in Vivo Phenotypic Screen to Characterize Selective Antimitotic Molecules. Comparative evaluation of Combretapyrazoles, -isoxazoles, -1,2,3-triazoles, and -pyrroles as Tubulin-Binding Agents.Marina N Semenova et al.ACS combinatorial science, 20(12), 700-721 (2018-11-20)
Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases.Chao Li et al.Frontiers in pharmacology, 11, 1247-1247 (2020-09-29)
Isoxazoles: synthesis, evaluation and bioinformatic design as acetylcholinesterase inhibitors.Margarita Gutiérrez et al.The Journal of pharmacy and pharmacology, 65(12), 1796-1804 (2013-11-05)
Ultrafast photodegradation of isoxazole and isothiazolinones by UV254 and UV254/H2O2 photolysis in a microcapillary reactor.Danilo Russo et al.Water research, 169, 115203-115203 (2019-11-02)
Selective Mediator dependence of cell-type-specifying transcription.Martin G Jaeger et al.Nature genetics, 52(7), 719-727 (2020-06-03)
Development and evaluation of small peptidomimetic ligands to protease-activated receptor-2 (PAR2) through the use of lipid tethering.Scott Boitano et al.PloS one, 9(6), e99140-e99140 (2014-06-14)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Name | CAS |
---|

Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!